Open Access

Comparison of pre‑implant treatment planning and post‑implant dosimetry in I‑125 spinal metastases brachytherapy

  • Authors:
    • Guohua Chen
    • Mingyong Han
  • View Affiliations

  • Published online on: November 18, 2019     https://doi.org/10.3892/ol.2019.11106
  • Pages: 309-316
  • Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

I‑125 seed therapy has been developed and used for the treatment of numerous types of malignancies. It has been suggested that post‑implant dosimetry deviates from pre‑implant treatment planning; however, to the best of our knowledge, very few studies to date have investigated this discrepancy. In the present study, 11 patients with metastatic spinal tumors, who were treated with I‑125 seed brachytherapy, were assessed. Pre‑ and post‑implant dosimetry were compared by assessing: Tumor volume, dose distributions and dose volume histograms. The average doses delivered to 90% of the target volume (D90) in the pre‑implant planning images of the spine was 119.07 Gy compared with 94.15 Gy in the post‑implant dosimetry (P<0.05). The average V100 in the pre‑implant planning images of the spine was 97.85% (range, 96.50‑99.80%), compared with 84.46% (range, 66.40‑96.70%) in the post‑implant dosimetry, of the prescribed doses (P<0.05). Furthermore, both the number of needles and the Dmax of the cord differed between the two groups. Nevertheless, the mean gross tumor volume, the number of seeds, and the V150 and V200 were similar between the two groups. The results of the present study suggest that metastatic spinal tumors of the bone received a lower dose than the pre‑implant planned dose coverage in I‑125 seed brachytherapy.
View Figures
View References

Related Articles

Journal Cover

January-2020
Volume 19 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chen G and Chen G: Comparison of pre‑implant treatment planning and post‑implant dosimetry in I‑125 spinal metastases brachytherapy. Oncol Lett 19: 309-316, 2020
APA
Chen, G., & Chen, G. (2020). Comparison of pre‑implant treatment planning and post‑implant dosimetry in I‑125 spinal metastases brachytherapy. Oncology Letters, 19, 309-316. https://doi.org/10.3892/ol.2019.11106
MLA
Chen, G., Han, M."Comparison of pre‑implant treatment planning and post‑implant dosimetry in I‑125 spinal metastases brachytherapy". Oncology Letters 19.1 (2020): 309-316.
Chicago
Chen, G., Han, M."Comparison of pre‑implant treatment planning and post‑implant dosimetry in I‑125 spinal metastases brachytherapy". Oncology Letters 19, no. 1 (2020): 309-316. https://doi.org/10.3892/ol.2019.11106